1 |
Burke RM, Groom HC, Naleway AL, Katz EM, Salas B, Mattison CP, Donald J, Tsaknaridis L, Biggs C, Bowen MD, Tate JE, Parashar UD, Schmidt M, Hall AJ. Rotavirus Vaccine Is Effective Against Rotavirus Gastroenteritis Resulting in Outpatient Care: Results From the Medically Attended Acute Gastroenteritis (MAAGE) Study. Clin Infect Dis 2021;72:2000-5. [PMID: 32322882 DOI: 10.1093/cid/ciaa466] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
2 |
Baker JM, Tate JE, Steiner CA, Haber MJ, Parashar UD, Lopman BA. Longer-term Direct and Indirect Effects of Infant Rotavirus Vaccination Across All Ages in the United States in 2000-2013: Analysis of a Large Hospital Discharge Data Set. Clin Infect Dis 2019;68:976-83. [PMID: 30020438 DOI: 10.1093/cid/ciy580] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
|
3 |
Bedelbaev M, Dzholbunova Z, Khalupko E. Comparative Clinical and Epidemiological Characteristics of Rotavirus Infection in Young Children. BSP 2020;6:135-146. [DOI: 10.33619/2414-2948/53/17] [Reference Citation Analysis]
|
4 |
Ai CE, Steele M, Lopman B. Disease burden and seasonal impact of improving rotavirus vaccine coverage in the United States: A modeling study. PLoS One 2020;15:e0228942. [PMID: 32059029 DOI: 10.1371/journal.pone.0228942] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
5 |
Payne DC, Englund JA, Weinberg GA, Halasa NB, Boom JA, Staat MA, Selvarangan R, Azimi PH, Klein EJ, Szilagyi PG, Chappell J, Sahni LC, McNeal M, Harrison CJ, Moffatt ME, Johnston SH, Mijatovic-Rustempasic S, Esona MD, Tate JE, Curns AT, Wikswo ME, Sulemana I, Bowen MD, Parashar UD. Association of Rotavirus Vaccination With Inpatient and Emergency Department Visits Among Children Seeking Care for Acute Gastroenteritis, 2010-2016. JAMA Netw Open 2019;2:e1912242. [PMID: 31560386 DOI: 10.1001/jamanetworkopen.2019.12242] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
|
6 |
Ndungo E, Pasetti MF. Functional antibodies as immunological endpoints to evaluate protective immunity against Shigella. Hum Vaccin Immunother 2020;16:197-205. [PMID: 31287754 DOI: 10.1080/21645515.2019.1640427] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
|
7 |
Getachew HB, Dahl RM, Lopman BA, Parashar UD. Rotavirus Vaccines and Health Care Utilization for Diarrhea in US Children, 2001 to 2015. Pediatr Infect Dis J 2018;37:943-8. [PMID: 29561514 DOI: 10.1097/INF.0000000000001988] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
|
8 |
Degiuseppe JI, Stupka JA. First assessment of all-cause acute diarrhoea and rotavirus-confirmed cases following massive vaccination in Argentina. Epidemiol Infect 2018;146:1948-54. [PMID: 30001762 DOI: 10.1017/S0950268818001954] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
9 |
Grytdal SP, Haberling DL, Kennedy JL, McCollum JT, Parashar UD. Sustained Decline in Acute Gastroenteritis-Associated Hospitalizations and Outpatient Visits Among American Indian/Alaska Native Children After Rotavirus Vaccine Introduction, 2001-2014. J Pediatric Infect Dis Soc 2018;7:e37-9. [PMID: 29309630 DOI: 10.1093/jpids/pix098] [Reference Citation Analysis]
|
10 |
Hoffman V, Abu-Elyazeed R, Enger C, Esposito DB, Doherty MC, Quinlan SC, Skerry K, Holick CN, Basile P, Friedland LR, Praet N, Wéry S, Willame C, Dore DD, Rosillon D. Safety study of live, oral human rotavirus vaccine: A cohort study in United States health insurance plans. Hum Vaccin Immunother 2018;14:1782-90. [PMID: 29533129 DOI: 10.1080/21645515.2018.1450123] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
|
11 |
Shah MP, Dahl RM, Parashar UD, Lopman BA. Annual changes in rotavirus hospitalization rates before and after rotavirus vaccine implementation in the United States. PLoS One 2018;13:e0191429. [PMID: 29444124 DOI: 10.1371/journal.pone.0191429] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
|